FINNEY ELISHA W

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$71,200.00
Insider Sells Quantity
12
Insider Sells Sum
$3.01M

Insider Activity of FINNEY ELISHA W

According to the SEC Form 4 filings, FINNEY ELISHA W, being in a position of

  1. director at ICU Medical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 300 shares for $31,484,
    over all time since 2020-08-13, has bought 0 shares, and sold 3925 shares for $842,625.

The largest purchase of all time was on 2018-05-11 and amounted to 2000 shares of Cutera, Inc. for $71,200.

The largest sale of all time was on 2015-06-02 and amounted to 20000 shares of Altair Engineering Inc. for $1.03M.

Biography of FINNEY ELISHA W

No biography is available at this moment.

2024-11-11SaleMettler-Toledo International Inc.
MTD
director
76
0.0004%
$1,311.75$99,693+0.36%
2024-05-16SaleICU Medical, Inc.
ICUI
director
300
0.0012%
$104.95$31,484+51.42%
2024-02-12SaleMettler-Toledo International Inc.
MTD
director
251
0.0011%
$1,177.35$295,515+13.61%
2023-06-07SaleICU Medical, Inc.
ICUI
director
194
0.0008%
$190.41$36,940-45.79%
2022-11-14SaleMettler-Toledo International Inc.
MTD
director
225
0.001%
$1,484.34$333,976-4.73%
2022-05-11SaleICU Medical, Inc.
ICUI
217
0.0009%
$170.53$37,005-4.65%
2021-09-14SaleICU Medical, Inc.
ICUI
director
2,424
0.0116%
$242.20$587,096-7.9%
2021-06-07SaleiRobot Corporation
IRBT
director
1,067
0.0037%
$97.48$104,011-26.68%
2021-03-12SaleiRobot Corporation
IRBT
director
480
0.0017%
$120.00$57,600-29.02%
2020-12-22SaleiRobot Corporation
IRBT
director
2,827
0.0098%
$85.00$240,295+2.92%
2020-08-13SaleICU Medical, Inc.
ICUI
director
790
0.0038%
$190.00$150,100+7.52%
2018-05-11PurchaseCutera, Inc.
CUTR
director
2,000
0.0139%
$35.60$71,200-44.46%
2015-06-02SaleAltair Engineering Inc.
ALTR
director
20,000
0.0115%
$51.73$1.03M
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.